Taro Pharmaceuticals U.S.A., Inc. recalls Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel…
Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria
Read the official notice →- Date
- 2022-01-19
- Country
- United States
- Brand
- Taro Pharmaceuticals U.S.A
- Product
- Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761,…
- Classification
- Class I
- Units
- Two distributors in UT and LA who could have further distributed to the retail…
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More Taro Pharmaceuticals U.S.A recalls
- 2024-08-21
USTaro Pharmaceuticals U.S.A., Inc. recalls Hydrocortisone 1% & Acetic Acid 2% Otic Solution, 10 mL bottle, Rx only, Mfg by: Taro Pharmaceuticals, Inc., Brampton,…
Failed Impurities/Degradation Specifications: Out-of-specification results obtained for related impurities and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.
FDA · DrugTaro Pharmaceuticals U.S.A., Inc.Product was distributed to one distributorOfficial notice →- 2022-04-06
- US
Taro Pharmaceuticals U.S.A., Inc. recalls Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%,15 g tubes, Rx only, Manufactured by: Taro Pharmaceuticals…
Failed Content Uniformity Specifications: Out-of-specification result for the Betamethasone Dipropionate assay of a stability sample
FDA · DrugTaro Pharmaceuticals U.S.A., Inc.Product was distributed to one retail consignee in NY.Official notice →
Other drugs & medical recalls in the United States
- 2022-01-19
- US
Ion Beam Applications S.A. recalls Proteus 235; Version: PTS-8 versions before PTS-8.7.2
Proton Therapy System (PTS) software can be started in the clinical environment (clinical user) while some processes are still running in the test environment (tcs user). Initiating the startup of the clinical…
- US
Technomed Europe recalls Disposable Subdermal Needle Electrode, Corkscrew, Single Use, Sterile; Model Numbers TE/S50715-001-C, TE/S50725-001C, and TE/S50715-001.
There is a high risk of the blue hub detaching from the corkscrew needle, resulting the the needle remaining in the patient's scalp.
FDA · DeviceTechnomed EuropeUS Nationwide distribution in the states of California, Florida, and Ohio.Official notice → - US
Akorn, Inc. recalls Sufentanil Citrate Injection, USP 100 mcg/2 mL (50 mcg/mL) for intravenous and epidural use, Rx only, 2 mL Ampule, Warning - May be habit…
Subpotent Drug: Out of specification for assay at the 30-month stability timepoint.
- US
- US
Teva Pharmaceuticals USA recalls MethylPREDNISolone Acetate Injectable Suspension USP 400 mg/10mL (40mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Manufactured for:…
Lack of Assurance of Sterility
FDA · DrugTeva Pharmaceuticals USAMethylprednisolone, TN Norepinephrine BItartrate - MS, OHOfficial notice → - US